World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

Arcline to Sell Resolution Medical to Resonetics

Cision PR Newswire by Cision PR Newswire
January 27, 2026
in Press Releases
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

NASHVILLE, Tenn., Jan. 27, 2026 /PRNewswire/ — Arcline Investment Management (“Arcline”), a growth-oriented private equity firm, today announced that it has entered into a definitive agreement to sell its portfolio company Resolution Medical to Resonetics.

Based in Fridley, Minnesota, Resolution Medical is a scaled, end-to-end engineering services and outsourced manufacturing partner focused on complex Class II and III devices for the most disruptive medical technology end markets including structural heart, cardiology and vascular, electrophysiology, and neuromodulation therapies. With 240 employees, more than 100 of whom are world-class engineers, Resolution Medical provides expertise in device design, prototyping, bio-simulation, and product design, through to finished device manufacturing. 

Peter Herman, CEO of Resolution Medical, commented, “With Arcline’s support, Resolution Medical has become a leader in the development and commercialization of cutting edge medical devices in the fastest-growing therapeutic modalities. We look forward to joining the Resonetics team and continuing our mission of supporting the most innovative technologies in interventional medicine to save lives and improve patient outcomes.”

“Resolution Medical is an exceptional organization with deep technical expertise, a strong innovation culture, and a proven track record in designing and developing complex medical devices for the most innovative companies,” said Kevin Kelly, CEO of Resonetics. “This acquisition enhances our ability to deliver fully integrated solutions for customers in high-growth markets like neuromodulation and structural heart, and supports our vision of becoming the most comprehensive partner in the medical device industry.”

The acquisition is expected to close in the first quarter of 2026, subject to regulatory approvals and customary closing conditions.

Piper Sandler & Co. served as financial advisor, and Bass, Berry & Sims PLC and Fredrikson & Byron P.A. served as legal advisors to Resolution Medical in connection with the transaction.

About Arcline Investment Management
Arcline Investment Management is a growth-oriented private equity firm with over $20 billion in assets under management. Arcline seeks to build the next generation of Industrial Compounders – market-leading, non-disruptible industrial platforms designed to consistently grow earnings over decades. For more information visit www.arcline.com.

Contact Information:
contact@arcline.com
www.arcline.com

Contact (For Press Inquiries Only):

Tim Ragones / Alexander Wolfsohn
Joele Frank, Wilkinson Brimmer Katcher
Arcline-JF@joelefrank.com
(212) 355-4449

Cision View original content:https://www.prnewswire.com/news-releases/arcline-to-sell-resolution-medical-to-resonetics-302671626.html

SOURCE Arcline Investment Management

Cision PR Newswire

Cision PR Newswire

Related Posts

Leaders and Experts from Amazon Web Services, Google, Microsoft, NVIDIA, Meta, Dell, Applied Materials and AMD Headline Technology and Innovation Programming at CERAWeek by S&P Global, March 23-27 in Houston

March 22, 2026

Optimax Eyewear Group Boosts US Manufacturing Capacity by 50% Following 30% YoY Growth

March 22, 2026

BRBR FINAL DEADLINE ALERT: BellRing Brands (BRBR) Facing Securities Class Action Amid Questions About Destocking, Consumption and Competition – Hagens Berman

March 22, 2026

IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial

March 22, 2026

ALIT DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Alight (ALIT) Investors of Securities Class Action Deadline on May 15, 2026

March 22, 2026

RGNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026

March 22, 2026

Popular News

  • Leaders and Experts from Amazon Web Services, Google, Microsoft, NVIDIA, Meta, Dell, Applied Materials and AMD Headline Technology and Innovation Programming at CERAWeek by S&P Global, March 23-27 in Houston

    0 shares
    Share 0 Tweet 0
  • BRBR FINAL DEADLINE ALERT: BellRing Brands (BRBR) Facing Securities Class Action Amid Questions About Destocking, Consumption and Competition – Hagens Berman

    0 shares
    Share 0 Tweet 0
  • Optimax Eyewear Group Boosts US Manufacturing Capacity by 50% Following 30% YoY Growth

    0 shares
    Share 0 Tweet 0
  • IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial

    0 shares
    Share 0 Tweet 0
  • POM DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler